Company: PGEN
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001356090-25-000034
Chunk: 28

Company: PRECIGEN, INC.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 1
Chunk 28
---
— 6,606 Shares issued upon vesting of restricted stock units and for exercises of stock options— — 1,514,394 — (1,514,394)— 346 — — 346 Shares issued for accrued compensation— — 2,170,885 — (2,170,885)— 3,039 — — 3,039 Shares issued as payment for services— — 385,783 — (385,783)— 553 — — 553 Shares issued in public offerings, net of issuance costs— — 39,878,939 — (3,408,369)— 30,882 — — 30,882 Net loss— — — — — — — — (106,508)(106,508)Release of cumulative translation adjustments to other income (expense), net— — — — — — — 2,915 — 2,915 Other comprehensive loss— — — — — — — (955)— (955)Balances at September 30, 2024— $— — 292,869,097 $— — $— $2,126,342 $13 $(2,070,979)$55,376 

The accompanying notes are an integral part of these condensed consolidated financial statements.

11

Precigen, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 Nine Months Ended  September 30,(Amounts in thousands)20252024Cash flows from operating activitiesNet loss$(227,139)$(106,508)Adjustments to reconcile net loss to net cash used in operating activities:Depreciation and amortization2,062 3,865 Loss (Gain) on disposals of assets, net14 (2)Impairment of goodwill3,907 1,630 Impairment of other noncurrent assets— 32,915 Loss on reclassification of cumulative foreign currency translation adjustments— 2,915 Change in fair value of warrant liabilities139,523 — Amortization of discounts on investments, net(1,492)(732)Stock-based compensation expense8,703 6,606 Shares issued as payment for services527 553